It should be noted that there is a report showing that SGLT2 inhibitors had no effects on ECG indices including QT interval in patients with type 2 diabetes in a cohort study, although indices of ventricle repolarization heterogeneity were not assessed in that study (61). This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.